Genencor Advances Biochemicals Production Using Zymetis’ Marine Microorganism

Zymetis Inc., a privately-held Maryland-based bioscience discovery company leading the way in bacterial reforming of complex biomass, today announces that Genencor, a division of Danisco A/S, has initiated an effort to explore novel methods for producing biochemicals directly from biomass feedstocks through use of the unique marine microorganism under development by Zymetis. Terms of the agreement were not disclosed.

“Aligning with Genencor, a leader in Industrial Biotechnology, helps us accomplish three corporate goals at once,” said Scott Laughlin, CEO of Zymetis. “First, it provides an opportunity to validate our technologies. Second, it offers a concrete commercialization path. And third, it provides the foundation for other key strategic alliances for us in the biochemicals industry.”